UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

FORM 15
 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g ) OF THE SECURITIES EXCHANGE ACT OF 1934
OF SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 000-53252
 

WAFERGEN BIO-SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
 


34700 Campus Drive
Fremont, CA 94555
(510) 651-4450
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
Common Stock, $0.001 par value
(Title of each class of securities covered by this Form)


(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
 
 
Rule 12g-4(a)(1)
 
x
 
 
Rule 12g-4(a)(2)
 
¨
 
 
Rule 12h-3(b)(1)(i)
 
x
 
 
Rule 12h-3(b)(1)(ii)
 
¨
 
 
Rule 15d-6
 
¨
 
Approximate number of holders of record as of the certification or notice date: One
 





Pursuant to the requirements of the Securities Exchange Act of 1934, WaferGen Bio-systems, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
 


 
 
 
 
 
 
 
Date: March 13, 2017
 
 
 
By:
 
/s/ Carol Lou
 
 
 
 
Name:
 
Carol Lou
 
 
 
 
Title:
 
President



WaferGen Bio-Systems, Inc. (NASDAQ:WGBS)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more WaferGen Bio-Systems, Inc. Charts.
WaferGen Bio-Systems, Inc. (NASDAQ:WGBS)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more WaferGen Bio-Systems, Inc. Charts.